Cell Systems’ primary human brain microvascular endothelial cells (ACBRI 376) and brain pericytes (ACBRI 498) are optimized for BBB modeling, drug transport, and neurovascular research.
These high-viability, early passage cells are isolated without antibody selection and validated across multiple peer-reviewed studies for expression of key markers including CD31, VEGF, IL-6, and miR-296.
With proven performance in co-culture, angiogenesis, inflammation, and gene expression assays, they’re ideal for 2D/3D culture, organ-on-chip, and brain cell platforms.
Key Features:
- Early passage cells, Passage 3 (<12 population doublings)
- Antibody-free isolation
- High viability (~85%), 1M cells per vial
- Supports 2D/3D culture, organ-on-chip, and co-culture
- Shipped as frozen vials or proliferating flasks
- Consistency across long-term studies with deep inventory from a single donor lot.
